Clinical Trials Directory

Trials / Unknown

UnknownNCT02194101

Supernormal Goal for Proximal Femur Fracture

Supernormal Oxygen Delivery May Not be a Valid Goal for Patients With Proximal Femur Fracture. An Observational Pilot Study

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Guangzhou First People's Hospital · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

This is an observational pilot study of supernormal oxygen delivery goal for patients with proximal femoral fracture.

Detailed description

Augmentation of oxygen delivery using fluids with or without inotropes has been shown to improve surgical outcome in high-risk patients. Patients with proximal femoral fracture are considered high risk. However, most of this cohort elderly patients have poor cardiovascular condition and may not achieve the oxygen delivery goal. We will perform an observational pilot study whether the supernormal oxygen delivery is a valid hemodynamic goal for patients with proximal femoral fracture.

Conditions

Interventions

TypeNameDescription
PROCEDURESupernormal oxygen delivery goal therapyA 10% increase in stroke volume (SV) after fluid challenge (5 ml/kg) with Ringer's lactate solution will be deemed positive. Oxygen delivery will be check when fluid challenge becomes negative. If oxygen delivery index (DO2I) can not be greater than 600 mL/m2, then dobutamine will be started at a dose of 2.5 μg/kg/min and increased by the same increment every 20 minutes until the described target is reached or until a maximal dose of 10 μg/kg/min is given. Dobutamine is decreased in dose or discontinued if the heart rate is above 100 beats per minute or shows signs of cardiac ischemia. Blood transfusions will be used to maintain a hemoglobin concentration over 8mg/dL.

Timeline

Start date
2014-08-01
Primary completion
2015-04-01
Completion
2015-06-01
First posted
2014-07-18
Last updated
2014-07-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02194101. Inclusion in this directory is not an endorsement.